These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30545661)

  • 1. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis.
    Moctezuma-Velazquez C; Ebadi M; Bhanji RA; Stirnimann G; Tandon P; Montano-Loza AJ
    Clin Nutr; 2019 Dec; 38(6):2696-2703. PubMed ID: 30545661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
    Vashi PG; Gorsuch K; Wan L; Hill D; Block C; Gupta D
    PLoS One; 2019; 14(6):e0218761. PubMed ID: 31220163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.
    Zeng X; Shi ZW; Yu JJ; Wang LF; Luo YY; Jin SM; Zhang LY; Tan W; Shi PM; Yu H; Zhang CQ; Xie WF
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1948-1958. PubMed ID: 34520115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of sarcopenia in patients with cirrhosis.
    Montano-Loza AJ
    World J Gastroenterol; 2014 Jul; 20(25):8061-71. PubMed ID: 25009378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Generated Subjective Global Assessment and Computed Tomography in the assessment of malnutrition and sarcopenia in patients with cirrhosis: Is there any association?
    Zambrano DN; Xiao J; Prado CM; Gonzalez MC
    Clin Nutr; 2020 May; 39(5):1535-1540. PubMed ID: 31307841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation.
    Vidot H; Kline K; Cheng R; Finegan L; Lin A; Kempler E; Strasser SI; Bowen DG; McCaughan GW; Carey S; Allman-Farinelli M; Shackel NA
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of different tools for the evaluation of malnutrition and sarcopenia in patients with liver cirrhosis].
    Aldana Ledesma JM; Vázquez Rodríguez D; Lazcano Becerra M; García Jiménez ES; Tapia Calderón DK; Ibarra Estrada MÁ; Félix Téllez FA; Velarde Ruiz Velasco JA
    Nutr Hosp; 2023 Apr; 40(2):340-346. PubMed ID: 36809904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and prognostic impact of malnutrition in a population screened for liver transplantation.
    Oey RC; Aarts P; Erler NS; Metselaar HJ; Lakenman PLM; Riemslag Baas-van der Ree S; van Kemenade MC; van Buuren HR; de Man RA
    Clin Nutr ESPEN; 2020 Apr; 36():36-44. PubMed ID: 32220367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
    Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
    Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
    Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
    Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
    Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between nutrition risk scores and sarcopenia in gastrointestinal cancer patients: a cross-sectional study.
    Gao B; Chen W; Liu Y; Li Y; Li X; Ding C; Guan W; Xu G; Chen X
    Support Care Cancer; 2022 Apr; 30(4):3269-3277. PubMed ID: 34981197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.
    Alvares-da-Silva MR; Reverbel da Silveira T
    Nutrition; 2005 Feb; 21(2):113-7. PubMed ID: 15723736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
    Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
    Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.
    Kim HY; Jang JW
    World J Gastroenterol; 2015 Jul; 21(25):7637-47. PubMed ID: 26167066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition and Muscle in Cirrhosis.
    Anand AC
    J Clin Exp Hepatol; 2017 Dec; 7(4):340-357. PubMed ID: 29234200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications.
    Majeed T; Sharma B; Sharma R; Bodh V; Chauhan A; Surya M; Mir BA; Sharma N; Sharma D
    Indian J Gastroenterol; 2024 Aug; 43(4):813-820. PubMed ID: 38849681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
    Ebadi M; Montano-Loza AJ
    Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of sarcopenia in patients with respiratory failure classified as normally nourished using computed tomography and subjective global assessment.
    Sheean PM; Peterson SJ; Gomez Perez S; Troy KL; Patel A; Sclamberg JS; Ajanaku FC; Braunschweig CA
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):873-9. PubMed ID: 23980135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
    Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
    Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.